The FDA Provides Answers to your Questions on the Medicine Ketek
Weitz and Luxenberg is no longer accepting Ketek cases.
Telithromycin is an FDA approved antibiotic medicine, which belongs to the ketolide class, marketed in the U.S. by Aventis under the brand name Ketek. Telithromycin was approved in the U.S. in April 2004.
Ketek (telithromycin) is indicated for the treatment of very serious bacterial infections, such as community-acquired pneumonia (including multi-drug resistant Streptococcus pneumoniae), acute bacterial sinusitis, and acute exacerbation of chronic bronchitis.
The FDA has received reports of liver-related adverse events in patients taking Ketek.
Patients who have been prescribed Ketek and are not suffering side effects such as jaundice should continue taking their medicine as prescribed. Patients who notice any yellowing of their eyes or skin or other problems like blurry vision should contact their healthcare providers.
Ketek should be stopped in patients who develop signs or symptoms of liver problems.
Telithromycin is marketed and used extensively in many other countries, including Japan and countries in Europe. The FDA is working with regulatory authorities in these other countries to obtain further information on reports of liver problems associated with the use of Ketek.
If you have experienced problems due to Ketek, it is important you fill out a form below for a free case evaluation.
see also:
Sanofi-Aventis
Learn more about a Ketek (Telithromycin) Lawsuit and Sanofi-AventisInfo on Sanofi-Aventis, makers of harmful drug Ketek (Telithromycin)
Facts
Ketek- What facts you need to knowKetek and your Health: All the facts Ketek users must know
Learn More
The drug Ketek (Telithromycin) can cause serious liver damage Ketek (Telithromycin) Dangers: Is your liver at risk? Learn more here.

